Morgan Stanley Hikes Price Target on Abbott Laboratories to $133 From $117By legume / January 8, 2023 / Abbott, Morgan Stanley Morgan Stanley Hikes Price Target on Abbott Laboratories (NYSE:ABT) to $133 From $117, Reiterates Overweight Rating.